Published in Eur Urol on April 01, 2003
Ultrasound and Pelvic Floor Muscle Training (ERP) | NCT04361890
Transobturator TVT-O versus retropubic TVT: results of a multicenter randomized controlled trial at 24 months follow-up. Int Urogynecol J (2010) 1.54
A validated self-administered female pelvic floor questionnaire. Int Urogynecol J (2009) 1.14
Anatomical and functional results of McCall culdoplasty in the prevention of enteroceles and vaginal vault prolapse after vaginal hysterectomy. Int Urogynecol J Pelvic Floor Dysfunct (2008) 1.00
Distress and quality of life characteristics associated with seeking surgical treatment for stress urinary incontinence. Health Qual Life Outcomes (2009) 0.95
A transvaginal ultrasound study comparing transobturator tape and tension-free vaginal tape after surgical treatment of female stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct (2005) 0.93
Australian pelvic floor questionnaire: a validated interviewer-administered pelvic floor questionnaire for routine clinic and research. Int Urogynecol J Pelvic Floor Dysfunct (2008) 0.91
Efficacy and perioperative safety of synthetic mid-urethral slings in obese women with stress urinary incontinence. Int Urogynecol J (2014) 0.89
Incontinence-specific quality of life measures used in trials of treatments for female urinary incontinence: a systematic review. Int Urogynecol J Pelvic Floor Dysfunct (2005) 0.89
Clinical and ultrasonographic correlations following three surgical anti-incontinence procedures (TOT, TVT and TVT-O). Int Urogynecol J Pelvic Floor Dysfunct (2008) 0.86
Intrasphincteric injections of autologous muscular cells in women with refractory stress urinary incontinence: a prospective study. Int Urogynecol J (2010) 0.82
TVT and TVT-O for surgical treatment of primary stress urinary incontinence: prospective randomized trial. Int Urogynecol J (2009) 0.82
Goal achievement as a patient-generated outcome measure for stress urinary incontinence. Health Expect (2009) 0.81
Reliability and clinical validity of a Polish version of the CONTILIFE: a quality of life questionnaire for urinary incontinence. Int Urogynecol J (2010) 0.75
75NC007 device for noninvasive stress urinary incontinence management in women: a randomized controlled trial. Int Urogynecol J (2012) 0.75
Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery. Eur Urol (2009) 2.41
Efficacy and safety of solifenacin plus tamsulosin OCAS in men with voiding and storage lower urinary tract symptoms: results from a phase 2, dose-finding study (SATURN). Eur Urol (2013) 2.18
Laparoscopic approach for artificial urinary sphincter implantation in women with intrinsic sphincter deficiency incontinence: a single-centre preliminary experience. Eur Urol (2009) 2.18
Validation of the Dutch version of the DN4 diagnostic questionnaire for neuropathic pain. Pain Pract (2012) 2.10
TVT-O for the treatment of pure urodynamic stress incontinence: efficacy, adverse effects, and prognostic factors at 5-year follow-up. Eur Urol (2012) 2.06
Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review. Eur Urol (2007) 2.04
PRO development: rigorous qualitative research as the crucial foundation. Qual Life Res (2010) 1.92
Impact of a patient education program on adherence to HIV medication: a randomized clinical trial. J Acquir Immune Defic Syndr (2003) 1.69
Duloxetine for mild to moderate postprostatectomy incontinence: preliminary results of a randomised, placebo-controlled trial. Eur Urol (2010) 1.56
Long-term functional outcomes after artificial urinary sphincter implantation in women with stress urinary incontinence. BJU Int (2014) 1.42
Secondary chemoprevention of localized prostate cancer by short-term androgen deprivation to select indolent tumors suitable for active surveillance: a prospective pilot phase II study. World J Urol (2013) 1.42
Prospective, multidimensional evaluation of sexual disorders in men after laser photovaporization of the prostate. J Sex Med (2013) 1.42
[Role of endoscopy in the management of upper urinary tract tumors]. Prog Urol (2006) 1.39
[Can a standard treatment be proposed for penile cancer?]. Prog Urol (2007) 1.39
Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cm. J Urol (2008) 1.35
Contribution of the oocyte to embryo quality. Theriogenology (2005) 1.32
Helical CT evaluation of the chemical composition of urinary tract calculi with a discriminant analysis of CT-attenuation values and density. Eur Radiol (2004) 1.29
Management of the complications of the synthetic slings. Curr Opin Urol (2006) 1.19
Body mass index and outcome of tension-free vaginal tape. Eur Urol (2003) 1.16
Objective and subjective cure rates after trans-obturator tape (OBTAPE) treatment of female urinary incontinence. Eur Urol (2005) 1.13
A widespread population study of actual medical management of lower urinary tract symptoms related to benign prostatic hyperplasia across Europe and beyond official clinical guidelines. Eur Urol (2010) 1.13
Measurement of health-related quality of life with glaucoma: validation of the Glau-QoL 36-item questionnaire. Acta Ophthalmol (2007) 1.11
A prospective study of sexual and urinary function before and after total mesorectal excision with autonomic nerve preservation for rectal cancer. Surgery (2002) 1.06
Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma. Urology (2006) 1.04
Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection. Eur Urol (2006) 1.02
Botulinum toxin-A (Botox) intradetrusor injections in children with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review. J Pediatr Urol (2009) 1.02
Vision-related quality of life in patients suffering from age-related macular degeneration. Am J Ophthalmol (2005) 1.01
Results of the tension-free vaginal tape technique in the elderly. Eur Urol (2003) 1.00
Stress incontinence injection therapy: what is best for our patients? Eur Urol (2005) 1.00
Influence of the severity of stress urinary incontinence on quality of life, health care seeking, and treatment: A national cross-sectional survey. Eur Urol (2006) 0.99
Comparison of mid-term carcinologic control obtained after open, laparoscopic, and robot-assisted radical prostatectomy for localized prostate cancer. World J Urol (2009) 0.98
An open, multicentre study of NASHA/Dx Gel (Zuidex) for the treatment of stress urinary incontinence. Eur Urol (2005) 0.97
Urine TMPRSS2:ERG fusion transcript integrated with PCA3 score, genotyping, and biological features are correlated to the results of prostatic biopsies in men at risk of prostate cancer. Prostate (2012) 0.97
Spontaneous rupture of non-tumoral kidneys in patients with end stage renal failure: risks and management. Eur Urol (2003) 0.97
Studying the Hurdles of Insulin Prescription (SHIP): development, scoring and initial validation of a new self-administered questionnaire. Health Qual Life Outcomes (2007) 0.97
A French multicenter clinical trial of SPARC for stress urinary incontinence. Eur Urol (2003) 0.95
[Epidemiology of urological emergencies in a teaching hospital]. Prog Urol (2002) 0.94
Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance. Urol Oncol (2009) 0.93
Arabidopsis HEAT SHOCK TRANSCRIPTION FACTORA1b overexpression enhances water productivity, resistance to drought, and infection. J Exp Bot (2013) 0.93
The impact of childhood acute rotavirus gastroenteritis on the parents' quality of life: prospective observational study in European primary care medical practices. BMC Pediatr (2012) 0.92
Comprehensive evaluation of bladder and urethral dysfunction symptoms: development and psychometric validation of the Urinary Symptom Profile (USP) questionnaire. Urology (2008) 0.90
[Bladder cancer in neurological patients: analysis of a single-centre series]. Prog Urol (2007) 0.89
[Prospective evaluation of the effects of a practical introduction to urology session on the recruitment of urology intern in Paris: final results]. Prog Urol (2007) 0.89
Aid to percutaneous renal access by virtual projection of the ultrasound puncture tract onto fluoroscopic images. J Endourol (2007) 0.88
Appraisal of patient-reported outcome instruments available for randomized clinical trials in dry eye: revisiting the standards. Ocul Surf (2012) 0.88
Oncological control after radical prostatectomy in men with clinical T3 prostate cancer: a single-centre experience. BJU Int (2008) 0.87
Transplanted bone marrow cells do not provide new oocytes but rescue fertility in female mice following treatment with chemotherapeutic agents. Cell Reprogram (2012) 0.87
[Palliative treatment of symptomatic benign prostatic hyperplasia by permanent urethral stent (Ultraflex, Boston Scientific) in high surgical risk patients]. Prog Urol (2007) 0.87
Diagnosis and management of adult female stress urinary incontinence: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians. Eur J Obstet Gynecol Reprod Biol (2010) 0.87
Artificial urinary sphincter (AMS 800) implantation for women with intrinsic sphincter deficiency: a technique for insiders? BJU Int (2010) 0.87
Management of lower urinary tract symptoms related to benign prostatic hyperplasia in real-life practice in france: a comprehensive population study. Eur Urol (2013) 0.86
De novo urinary stress incontinence after laparoscopic sacral colpopexy. BJU Int (2007) 0.86
Functional outcomes after pure laparoscopic or robot-assisted pyeloplasty. Actas Urol Esp (2009) 0.86
Complications of urethral sling procedures. Curr Opin Obstet Gynecol (2002) 0.85
Patient-reported benefit of ReSTOR multi-focal intraocular lenses after cataract surgery: results of principal component analysis on clinical trial data. Health Qual Life Outcomes (2008) 0.85
The role of a well-trained team on the early learning curve of robot-assisted laparoscopic procedures: the example of radical prostatectomy. Int J Med Robot (2012) 0.85
Outcome and cost analysis of sacral nerve modulation for treating urinary and/or fecal incontinence. Ann Surg (2011) 0.84
Oncologic control provided by HIFU therapy as single treatment in men with clinically localized prostate cancer. World J Urol (2008) 0.84
Corrected and uncorrected near and distance vision with ReSTOR compared to monofocal intraocular lens implantation after cataract surgery: a pooled analysis. Ophthalmologica (2008) 0.84
Tension-free vaginal tape and associated procedures: a case control study. Eur Urol (2004) 0.84
Oncologic control obtained after radical prostatectomy in men with a pathological Gleason score ≥ 8: a single-center experience. Urol Oncol (2009) 0.84
Surgical resection for suburethral sling complications after treatment for stress urinary incontinence. J Urol (2009) 0.83
Phenol sulfotransferase SULT1A1*2 allele and enhanced risk of upper urinary tract urothelial cell carcinoma. Cancer Epidemiol Biomarkers Prev (2007) 0.83
Improvement in quality of sexual life in female partners of men with erectile dysfunction treated with sildenafil citrate: findings of the Index of Sexual Life (ISL) in a couple study. J Sex Med (2009) 0.83
Multinational development of a questionnaire assessing patient satisfaction with anticoagulant treatment: the 'Perception of Anticoagulant Treatment Questionnaire' (PACT-Q). Health Qual Life Outcomes (2009) 0.83
Pelvic organ prolapse transvaginal repair by the Prolift system: evaluation of efficacy and complications after a 4.5 years follow up. Int J Urol (2012) 0.82
Oncologic outcome after radical prostatectomy in men with PSA values above 20 ng/ml: a monocentric experience. World J Urol (2009) 0.82
What's new in prolapse surgery? Curr Opin Urol (2003) 0.82
Irbesartan is projected to be cost and life saving in a Spanish setting for treatment of patients with type 2 diabetes, hypertension, and microalbuminuria. Kidney Int Suppl (2005) 0.81
[French multicentre prospective study of the use of ACT balloons (Uromedica, Inc., Plymouth, Min, U.S.A.; Medtronic, Minneapolis, U.S.A.) for the treatment of female stress urinary incontinence]. Prog Urol (2007) 0.81
Evolution of the landscape of surgical management of prostate cancer in France: the case of radical prostatectomy. Eur Urol (2012) 0.80
Impact on parents of bronchiolitis hospitalization of full-term, preterm and congenital heart disease infants. BMC Pediatr (2012) 0.80
Aurora-A/STK-15 is differentially expressed in the micropapillary variant of bladder cancer. Urol Int (2009) 0.80
[Artificial urinary sphincters in women: indications, techniques, results]. Prog Urol (2005) 0.79
Late recurrence of a prostatic adenocarcinoma as a solitary splenic metastasis. Urol Int (2007) 0.79
Assessing the complications of laparoscopic robot-assisted surgery: the case of radical prostatectomy. Surg Endosc (2010) 0.79
Update in management of vaginal mesh erosion. Curr Urol Rep (2013) 0.79
A new preservation solution increases islet yield and reduces graft immunogenicity in pancreatic islet transplantation. Transplantation (2007) 0.79
[Terminology of lower urinary tract dysfunction: French adaptation of the terminology of the International Continence Society]. Prog Urol (2004) 0.78
Clinical relevance of urethral stents (Urospiral 2™) placement in patients with prostatic obstacle and concomitant high-risk surgical status or neurological diseases: a feasibility and safety study. Neurourol Urodyn (2010) 0.78
A pragmatic approach to the characterization and effective treatment of male patients with postprostatectomy incontinence. Curr Opin Urol (2014) 0.78
Long-term benefits of darifenacin treatment for patient quality of life: results from a 2-year extension study. Neurourol Urodyn (2008) 0.78
Patients' experience and perception of hospital-treated Clostridium difficile infections: a qualitative study. Patient (2014) 0.78
[How to identify the neck of a caliceal diverticulum in flexible ureterorenoscopy]. Prog Urol (2005) 0.78
Long-term treatment acceptance: what is it, and how can it be assessed? Patient (2012) 0.78
Assessing patients' satisfaction with anti-TNFα treatment in Crohn's disease: qualitative steps of the development of a new questionnaire. Clin Exp Gastroenterol (2011) 0.78
TVT SECUR single-incision sling after 5 years of follow-up: the promises made and the promises broken. Eur Urol (2012) 0.78
[How to avoid accumulation of stone fragments in the lower calix during flexible ureterorenoscopy]. Prog Urol (2005) 0.78
Measuring benefits and patients' satisfaction when glasses are not needed after cataract and presbyopia surgery: scoring and psychometric validation of the Freedom from Glasses Value Scale (FGVS). BMC Ophthalmol (2010) 0.78
Development of a new subjective questionnaire: the Freedom from Glasses Value Scale (FGVS). J Refract Surg (2010) 0.78
Linguistic validation into 20 languages and content validity of the rheumatoid arthritis-specific Work Productivity and Activity Impairment questionnaire. Patient (2014) 0.78
A French cost-consequence analysis of the renoprotective benefits of irbesartan in patients with type 2 diabetes and hypertension. Curr Med Res Opin (2006) 0.77
Impact of genotyping on outcome of prostatic biopsies: a multicenter prospective study. Mol Med (2011) 0.77